Header cover image

French (CAC) Biotech Industry Analysis

UpdatedDec 05, 2023
DataAggregated Company Financials
Companies29
  • 7D-0.3%
  • 3M-23.8%
  • 1Y-10.4%
  • YTD-13.4%

Over the last 7 days, the Biotech industry has dropped 1.3%, driven by declines in DBV Technologies and Acticor Biotech SAS of 7.7% and 22%, respectively. The industry has fallen 9.9% in the last year. As for the next few years, earnings are expected to grow by 46% per annum.

Industry Valuation and Performance

Has the French Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 05 Dec 2023€3.2b€594.7m-€685,255,395.0021.7x-4.6x5.3x
Thu, 02 Nov 2023€3.1b€803.5m-€567,784,769.0021x-5.5x3.9x
Sat, 30 Sep 2023€3.3b€827.5m-€579,145,511.0014.2x-5.8x4x
Mon, 28 Aug 2023€3.7b€818.2m-€727,289,207.0024.1x-5.1x4.5x
Wed, 26 Jul 2023€3.8b€817.5m-€734,744,130.0024.5x-5.2x4.6x
Fri, 23 Jun 2023€3.9b€819.7m-€742,987,860.0025.3x-5.3x4.8x
Sun, 21 May 2023€3.8b€831.2m-€761,674,629.0026.1x-4.9x4.5x
Tue, 18 Apr 2023€3.5b€878.2m-€769,875,315.0031.6x-4.5x4x
Thu, 16 Mar 2023€3.3b€1.0b-€470,273,558.009.7x-7x3.2x
Sat, 11 Feb 2023€3.7b€1.0b-€457,392,283.0011.5x-8.1x3.5x
Mon, 09 Jan 2023€3.7b€1.0b-€455,883,646.0012.1x-8x3.5x
Wed, 07 Dec 2022€3.5b€1.0b-€457,899,023.0012.6x-7.5x3.3x
Fri, 04 Nov 2022€3.6b€914.4m-€705,389,452.0016.5x-5.1x3.9x
Sun, 02 Oct 2022€3.2b€923.3m-€677,984,751.0031x-4.7x3.5x
Tue, 30 Aug 2022€4.4b€930.8m-€751,667,630.00115x-5.8x4.7x
Thu, 28 Jul 2022€4.4b€985.5m-€688,213,309.00120.9x-6.3x4.4x
Sat, 25 Jun 2022€4.7b€993.1m-€693,029,894.00126x-6.7x4.7x
Mon, 23 May 2022€4.7b€991.3m-€692,391,260.00134.4x-6.8x4.8x
Wed, 20 Apr 2022€5.1b€1.2b-€489,700,261.003x-10.5x4.2x
Fri, 18 Mar 2022€5.5b€950.8m-€648,046,770.0017.4x-8.5x5.8x
Sun, 13 Feb 2022€5.4b€929.8m-€675,308,815.003x-7.9x5.8x
Tue, 11 Jan 2022€6.1b€931.7m-€678,654,271.003.2x-9x6.5x
Thu, 09 Dec 2021€6.9b€923.1m-€680,995,918.002.7x-10.1x7.4x
Sat, 06 Nov 2021€6.5b€921.3m-€672,182,761.002.3x-9.7x7.1x
Mon, 04 Oct 2021€6.8b€902.4m-€738,666,719.002.6x-9.2x7.5x
Wed, 01 Sep 2021€7.7b€899.6m-€600,532,159.122.9x-12.8x8.5x
Thu, 08 Jul 2021€6.5b€899.6m-€600,532,159.122.8x-10.8x7.2x
Wed, 31 Mar 2021€6.9b€882.0m-€570,006,611.924x-12.1x7.8x
Sat, 02 Jan 2021€6.5b€911.8m-€514,619,691.4221.4x-12.6x7.1x
Price to Earnings Ratio

-12.6x


Total Market Cap: €6.5bTotal Earnings: -€514,619,691.42Total Revenue: €911.8mTotal Market Cap vs Earnings and Revenue0%0%0%
French Biotech Industry Price to Earnings3Y Average -8.2x20222023
Current Industry PE
  • Investors are relatively neutral on the French Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 5.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Revenues have also declined 6.9% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Trends

Which industries have driven the changes within the French Healthcare industry?

FR Market0.43%
Healthcare0.31%
Biotech-0.27%
Biotech-0.27%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ABVX ABIVAX Société Anonyme€9.401.6%
+€9.4m
41.1%PS29443.6x
ALCLS Cellectis€2.653.1%
+€5.7m
22.4%PS8.4x
VLA Valneva€5.220.7%
+€5.3m
-25.2%PS3.2x
ADOC Adocia€8.234.8%
+€5.3m
165.1%PS10.5x
MAAT MaaT Pharma€7.002.9%
+€2.3m
-22.2%PS35.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

VLA

€5.22

Valneva

7D

0.7%

1Y

-25.2%

MAAT

€7.00

MaaT Pharma

7D

2.9%

1Y

-22.2%

ABVX

€9.40

ABIVAX Société Anonyme

7D

1.6%

1Y

41.1%

ALSEN

€0.47

Sensorion

7D

-4.6%

1Y

17.7%

ALACT

€2.96

Acticor Biotech SAS

7D

-19.6%

1Y

-60.0%

ADOC

€8.23

Adocia

7D

4.8%

1Y

165.1%

NANO

€5.12

Nanobiotix

7D

-2.1%

1Y

30.6%

ALCLS

€2.65

Cellectis

7D

3.1%

1Y

22.4%

ALERS

€15.98

Eurobio Scientific Société anonyme

7D

-2.6%

1Y

-19.3%

IPH

€2.25

Innate Pharma

7D

-1.8%

1Y

3.5%

IVA

€3.98

Inventiva

7D

0.5%

1Y

-9.2%

PHXM

€4.44

PHAXIAM Therapeutics

7D

5.5%

1Y

-29.3%

TNG

€1.46

Transgene

7D

0.7%

1Y

-23.8%

ALVAL

€5.38

Valbiotis

7D

-4.3%

1Y

49.4%